Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/114129
Title: Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences
Author: Moran, Sebastian
Arribas, Carles
Esteller, Manel
Keywords: Metilació
ADN
Epigènesi
Microxips d'ADN
Genoma humà
Methylation
DNA
Epigenesis
DNA microarrays
Human genome
Issue Date: Mar-2016
Publisher: Future Medicine
Abstract: DNA methylation is the best known epigenetic mark. Cancer and other pathologies show an altered DNA methylome. However, delivering complete DNA methylation maps is compromised by the price and labor-intensive interpretation of single nucleotide methods. MATERIAL & METHODS: Following the success of the HumanMethylation450 BeadChip (Infinium) methylation microarray (450K), we report the technical and biological validation of the newly developed MethylationEPIC BeadChip (Infinium) microarray that covers over 850,000 CpG methylation sites (850K). The 850K microarray contains >90% of the 450K sites, but adds 333,265 CpGs located in enhancer regions identified by the ENCODE and FANTOM5 projects. RESULTS & CONCLUSION: The 850K array demonstrates high reproducibility at the 450K CpG sites, is consistent among technical replicates, is reliable in the matched study of fresh frozen versus formalin-fixed paraffin-embeded samples and is also useful for 5-hydroxymethylcytosine. These results highlight the value of the MethylationEPIC BeadChip as a useful tool for the analysis of the DNA methylation profile of the human genome.
Note: Reproducció del document publicat a: https://doi.org/10.2217/epi.15.114
It is part of: Epigenomics, 2016, vol. 8, num. 3, p. 389-399
Related resource: https://doi.org/10.2217/epi.15.114
URI: http://hdl.handle.net/2445/114129
ISSN: 1750-1911
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
662713.pdf1.72 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons